Daniel J. Lippis, CVP of TAVR at Edwards Lifesciences Corp ($EW), sold shares on the open market seven times in the past year for a total of $717 thousand. His latest sale occurred on March 11, 2026. These transactions rank 5,681st among 11,678 insiders in our database, trailing the average sale value of $8.6 million over 6.37 transactions. Lippis made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | M | Common Stock | 1019 | $59.26 | 34,952.9103 | 658,200,000 | 3.00% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 3,057.0000 | 658,200,000 | 25.00% | 0.00% |
| March 11, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | S | Common Stock | 1019 | $85.38 | 33,933.9103 | 658,200,000 | 2.92% | 0.00% |
| Feb. 22, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 432 | $79.78 | 33,933.9103 | 658,200,000 | 1.26% | 0.00% |
| Feb. 12, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | A | Common Stock | 12820 | $0.00 | 34,821.9103 | 658,200,000 | 58.27% | 0.00% |
| Feb. 16, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 258 | $75.87 | 34,563.9103 | 658,200,000 | 0.74% | 0.00% |
| Feb. 17, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | F | Common Stock | 198 | $75.87 | 34,365.9103 | 658,200,000 | 0.57% | 0.00% |
| Jan. 9, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | S | Common Stock | 1019 | $85.70 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| Jan. 9, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | M | Common Stock | 1019 | $59.26 | 23,020.9103 | 658,200,000 | 4.63% | 0.00% |
| Jan. 9, 2026 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, TAVR | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 4,076.0000 | 658,200,000 | 20.00% | 0.00% |
| Dec. 12, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1019 | $59.26 | 23,020.9103 | 658,200,000 | 4.63% | 0.00% |
| Dec. 12, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1019 | $0.00 | 5,095.0000 | 658,200,000 | 16.67% | 0.00% |
| Dec. 12, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1019 | $84.03 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1020 | $0.00 | 6,114.0000 | 658,200,000 | 14.30% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1020 | $59.26 | 23,021.9103 | 658,200,000 | 4.64% | 0.00% |
| Nov. 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1020 | $82.55 | 22,001.9103 | 658,200,000 | 4.43% | 0.00% |
| July 28, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 4114 | $79.46 | 22,001.9103 | 657,600,000 | 15.75% | 0.00% |
| July 7, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 333 | $76.79 | 26,115.9103 | 657,600,000 | 1.26% | 0.00% |
| May 11, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 271 | $73.68 | 26,345.1066 | 655,900,000 | 1.02% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Employee Stock Option (Right to Acquire) | 21500 | $0.00 | 21,500.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 330 | $74.42 | 26,616.1066 | 655,900,000 | 1.22% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Performance Rights | 4225 | $0.00 | 4,225.0000 | 655,900,000 | 9999.99% | 0.00% |
| May 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 4225 | $0.00 | 26,616.1066 | 655,900,000 | 18.87% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 330 | $0.00 | 0.0000 | 655,900,000 | 100.00% | 0.00% |
| May 9, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 330 | $45.28 | 26,946.1066 | 655,900,000 | 1.24% | 0.00% |
| May 3, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 225 | $75.65 | 22,638.1066 | 655,900,000 | 0.98% | 0.00% |
| May 4, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 247 | $75.65 | 22,391.1066 | 655,900,000 | 1.09% | 0.00% |
| April 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 300 | $45.28 | 23,163.1066 | 655,900,000 | 1.31% | 0.00% |
| April 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 300 | $0.00 | 330.0000 | 655,900,000 | 47.62% | 0.00% |
| April 8, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 300 | $70.61 | 22,863.1066 | 655,900,000 | 1.30% | 0.00% |
| March 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 400 | $0.00 | 630.0000 | 654,800,000 | 38.83% | 0.00% |
| March 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 400 | $45.28 | 22,988.0651 | 654,800,000 | 1.77% | 0.00% |
| March 10, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 400 | $69.48 | 22,588.0651 | 654,800,000 | 1.74% | 0.00% |
| Feb. 16, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 214 | $76.19 | 22,975.0651 | 654,800,000 | 0.92% | 0.00% |
| Feb. 18, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 222 | $76.19 | 22,588.0651 | 654,800,000 | 0.97% | 0.00% |
| Feb. 17, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 165 | $76.19 | 22,810.0651 | 654,800,000 | 0.72% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 654,800,000 | 2.16% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $76.34 | 23,189.0651 | 654,800,000 | 2.11% | 0.00% |
| Feb. 13, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 1,030.0000 | 654,800,000 | 32.68% | 0.00% |
| Jan. 16, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 1,530.0000 | 654,800,000 | 24.63% | 0.00% |
| Jan. 16, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 654,800,000 | 2.16% | 0.00% |
| Jan. 16, 2025 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $68.76 | 23,189.0651 | 654,800,000 | 2.11% | 0.00% |
| Dec. 16, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 2500 | $0.00 | 2,030.0000 | 654,300,000 | 55.19% | 0.00% |
| Dec. 16, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 2500 | $45.28 | 25,689.0651 | 654,300,000 | 10.78% | 0.00% |
| Dec. 16, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 2500 | $74.08 | 23,189.0651 | 654,300,000 | 9.73% | 0.00% |
| July 11, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 500 | $94.18 | 23,189.0651 | 653,500,000 | 2.11% | 0.00% |
| July 11, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 500 | $45.28 | 23,689.0651 | 653,500,000 | 2.16% | 0.00% |
| July 11, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 500 | $0.00 | 4,530.0000 | 653,500,000 | 9.94% | 0.00% |
| July 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 410 | $92.32 | 23,189.0651 | 653,500,000 | 1.74% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 535 | $45.28 | 24,047.7443 | 651,800,000 | 2.28% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 535 | $90.00 | 23,512.7443 | 651,800,000 | 2.22% | 0.00% |
| June 20, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 535 | $0.00 | 5,030.0000 | 651,800,000 | 9.61% | 0.00% |
| May 11, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 377 | $86.72 | 23,512.7443 | 651,800,000 | 1.58% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Performance Rights | 2900 | $0.00 | 2,900.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 857 | $0.00 | 0.0000 | 651,800,000 | 100.00% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Employee Stock Option (Right to Acquire) | 15500 | $0.00 | 15,500.0000 | 651,800,000 | 9999.99% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 857 | $85.60 | 23,889.7443 | 651,800,000 | 3.46% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 586 | $85.09 | 24,746.7443 | 651,800,000 | 2.31% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 857 | $36.75 | 25,332.7443 | 651,800,000 | 3.50% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 2900 | $0.00 | 24,475.7443 | 651,800,000 | 13.44% | 0.00% |
| May 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | A | Common Stock | 4660 | $0.00 | 21,575.7443 | 651,800,000 | 27.55% | 0.00% |
| May 4, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 291 | $85.25 | 16,915.7443 | 651,800,000 | 1.69% | 0.00% |
| May 3, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 281 | $85.06 | 17,206.7443 | 651,800,000 | 1.61% | 0.00% |
| April 9, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 857 | $92.34 | 17,487.7443 | 651,800,000 | 4.67% | 0.00% |
| April 9, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 857 | $36.75 | 18,344.7443 | 651,800,000 | 4.90% | 0.00% |
| April 9, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 857 | $0.00 | 857.0000 | 651,800,000 | 50.00% | 0.00% |
| March 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Employee Stock Option (Right to Acquire) | 1715 | $0.00 | 1,714.0000 | 650,500,000 | 50.01% | 0.00% |
| March 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | S | Common Stock | 1715 | $90.98 | 17,213.2105 | 650,500,000 | 9.06% | 0.00% |
| March 7, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | M | Common Stock | 1715 | $36.75 | 18,928.2105 | 650,500,000 | 9.96% | 0.00% |
| Feb. 18, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 188 | $86.10 | 17,213.2105 | 650,500,000 | 1.08% | 0.00% |
| Feb. 17, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 150 | $86.10 | 17,401.2105 | 650,500,000 | 0.85% | 0.00% |
| Feb. 16, 2024 | Edwards Lifesciences Corp | $EW | Lippis Daniel J. | CVP, JAPAC | F | Common Stock | 207 | $86.04 | 17,551.2105 | 650,500,000 | 1.17% | 0.00% |